4//SEC Filing
Smith Michael David 4
Accession 0001209191-22-030568
CIK 0001348911other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:59 PM ET
Size
8.4 KB
Accession
0001209191-22-030568
Insider Transaction Report
Form 4
Smith Michael David
Sr. VP, Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-05-17+10,320→ 10,320 totalExercise: $9.28Exp: 2032-05-16→ Common Stock (10,320 underlying) - Award
Restricted Stock Units
2022-05-17+15,480→ 15,480 total→ Common Stock (15,480 underlying)
Footnotes (3)
- [F1]The option vests over a 4 year period: 1/48th on June 17,2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]1/16th of the total RSUs subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001777800
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:59 PM ET
- Size
- 8.4 KB